Clinical Trial Update: Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating datopotamab deruxtecan plus platinum chemotherapy versus gemcitabine plus platinum in locally advanced or metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Datopotamab Deruxtecan (Dato-DXd) (datopotamab deruxtecan)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Urothelial Cancer, Bladder Cancer | Phase 2, Phase 3 | Status: RECRUITING